Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Disease Management Could End Need For Rx Benefit-CBO's Crippen

Executive Summary

A disease management program that includes prescription drug coverage could eliminate the need for a universal prescription drug benefit, Congressional Budget Office Director Dan Crippen suggested.

You may also be interested in...



Medicare Disease Management Should Focus On Part B Drugs – AdvancePCS

AdvancePCS is recommending that Medicare disease management initiatives begin with programs that would address Part B-covered drug

Medicare Disease Management Should Focus On Part B Drugs – AdvancePCS

AdvancePCS is recommending that Medicare disease management initiatives begin with programs that would address Part B-covered drug

UnitedHealth Disease Management Is Model For Medicare, Bush Says

UnitedHealth Group's EverCare disease management program is an example of the right approach to caring for seniors under Medicare, President Bush said during a speech in Minneapolis July 11

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS038704

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel